Analyst Ratings for Regenxbio Inc. (RGNX)
RGNX Rating Summary
RGNX Price Target Summary
- Highest: $45.00 (Clear Street)
- Lowest: $10.00 (Goldman Sachs)
- Average: $23.55
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$23.55 (+239.8%)
* Over Last 12-Mos
Rating Score: 8.3 / 10
Percentile Rank: 85%
Avg. $ Target:
$23.55 (+239.8%)
* Over Last 12-Mos
Rating Score: 8.3 / 10
Percentile Rank: 85%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/5/2026 | Mizuho | Graig Suvannavejh | New Coverage | Outperform (N/A) |
22.00 (N/A) |
7.42 (6.93) |
-6.6% | Details |
| 8/7/2026 | Barclays | Eliana Merle | Downgrade | Equalweight (Overweight) |
12.00 (N/A) |
10.50 (10.50) |
0% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
